• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

EyeCare America receives $1.125 million grant

Article

San Francisco-EyeCare America, the public service program of the Foundation of the American Academy of Ophthalmology (FAAO), received a $1.125 million grant from Alcon Laboratories Inc., Fort Worth, TX.

San Francisco-EyeCare America, the public service program of the Foundation of the American Academy of Ophthalmology (FAAO), received a $1.125 million grant from Alcon Laboratories Inc., Fort Worth, TX.

The 5-year unrestricted grant will support EyeCare America's Senior EyeCare program, which bridges the health-care gap for an aging U.S. population. Through the program those who are eligible receive a dilated medical examination and up to 1 year of treatment at no out-of-pocket cost.

Today, more than two-thirds of visually impaired adults in the United States are over 65 years of age. The prevalence of blindness increases rapidly in the later years, particularly after age 75. The number of Americans with age-related eye disease is expected to double within the next 3 decades unless something is done to reverse the trend.

"Alcon is delighted to support this most worthwhile program," said Cary Rayment, Alcon's president and chief executive officer. "As a company, we have a commitment to give back to the community, and partnering with the Seniors EyeCare Program is an excellent way to fulfill that commitment."

To determine if a person qualifies for a referral, call the toll-free helpline 800/ 222-EYES (3937), which is available 24 hours a day, every day throughout the year.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.